CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Medical Officer sold 5,602 shares at $1.42 ($7,965)
- 4 Open-market sale Chief Financial Officer sold 3,949 shares at $1.42 ($5,617)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise President and CEO acquired 90,931 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Chief Development Officer acquired 40,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 22,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 22,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 20 · 400 filings